All In Biotech

Drug Trial Radar · NCT07676084

Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease

A Randomized, Investigator-Masked, Single-Center Study Evaluating Tolerability, Symptomatic Improvement, and Visual Functional Outcomes With the Use of Over-the-Counter Lubricating Eye Drops in Subjects With Dry Eye Disease

Last checked: Nov 20, 2026Latest source record: Jun 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Jun 3, 2026

Primary completion

Oct 2026

Study completion Dec 2026

Sponsor

Lead sponsor
Andover Research Eye InstituteIndustry
Sponsor type
Industry
First posted
Jun 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study to evaluate the effect of over- the- counter (OTC) lubricating eye drops on tolerability, symptoms and visual outcomes in patients with dry eye disease (DED)

Conditions

  • Dry Eye Disease (DED)

Interventions

  • Preservative Free Polyethylene glycol 400 0.25%Drug

    4 times daily \[QID\]

  • Propylene Glycol (0.6%)Drug

    Preservative Free Propylene Glycol (0.6%)

  • Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%Drug

    QID Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Ocular Surface Disease Index (OSDI)Time frame: 14 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Andover Eye Associates

    Andover, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.